Finance

Lists
Why is MBX down 6,78%?
Dive Deeper
MBX:TSE
Microbix Biosystems Inc
0,28 CAD
-6,78%
(-0,020) 1D
20-ноя., 16:00:00 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MBX...
Open
0,30 CAD
High
0,30 CAD
Low
0,28 CAD
Mkt. cap
37,44 млн
Avg. vol.
30,14 миң
Volume
27,86 миң
52-wk high
0,32 CAD
52-wk low
0,21 CAD
EPS
-0,04 CAD
Beta
0,54
Shares outstanding
136,97 млн
No. of employees
70
Open
0,30 CAD
High
0,30 CAD
Low
0,28 CAD
Mkt. cap
37,44 млн
Avg. vol.
30,14 миң
Volume
27,86 миң
52-wk high
0,32 CAD
52-wk low
0,21 CAD
EPS
-0,04 CAD
Beta
0,54
Shares outstanding
136,97 млн
No. of employees
70
News stories
From web sources and news partners
About Microbix Biosystems Inc
CEO-
Employees70
Founded1988
HeadquartersМиссисога, Онтарио, Канада
SectorHealth Care
Industry-
Last report
2026-ж., 13-авг.
Fiscal period
Q3 2026
- / -
Revenue / Est. (USD)
2,91 млн / 3,78 млн
-22,95%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
3,74 млн
4,22 млн
3,38 млн
4,06 млн
Cost of goods sold
2,23 млн
2,49 млн
1,75 млн
1,87 млн
Cost of revenue
2,23 млн
2,49 млн
1,75 млн
1,87 млн
Research and development expenses
626,76 миң
557,07 миң
601,29 миң
578,22 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,30 млн
2,13 млн
2,29 млн
2,27 млн
Operating expense
2,92 млн
2,68 млн
2,89 млн
2,85 млн
Total operating expenses
5,15 млн
5,17 млн
4,64 млн
4,72 млн
Operating income
-1,41 млн
-949,19 миң
-1,26 млн
-658,18 миң
Other non operating income
1,00
1,00
-
-1,00
EBT including unusual items
-1,54 млн
-1,17 млн
-1,43 млн
-806,76 миң
EBT excluding unusual items
-1,54 млн
-1,17 млн
-1,43 млн
-806,76 миң
Income tax expense
-55,73 миң
-
-
-
Effective tax rate
3,63%
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,48 млн
-1,17 млн
-1,43 млн
-806,76 миң
Net profit margin
-39,54%
-27,67%
-42,35%
-19,87%
Earnings per share
-
-
-
-
Interest and investment income
74,68 миң
71,52 миң
62,37 миң
49,76 миң
Interest expense
-243,00 миң
-251,72 миң
-256,38 миң
-261,21 миң
Net interest expenses
-168,32 миң
-180,20 миң
-194,01 миң
-211,45 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,04 млн
-592,76 миң
-798,84 миң
-186,45 миң
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору